VSee Health, Inc.
VSEE
$1.05
$0.043.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 124.17% | 111.50% | 82.91% | 38.30% | 5.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 124.17% | 111.50% | 82.91% | 38.30% | 5.03% |
| Cost of Revenue | 155.57% | 173.31% | 90.97% | 38.41% | 21.93% |
| Gross Profit | 106.90% | 84.85% | 78.85% | 38.24% | -2.40% |
| SG&A Expenses | 216.19% | 185.11% | 113.07% | 25.96% | -20.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 205.57% | 182.10% | 107.41% | 28.92% | -11.67% |
| Operating Income | -637.89% | -567.60% | -186.47% | -4.37% | 52.12% |
| Income Before Tax | -2,087.57% | -5,367.91% | -3,027.75% | -2,060.77% | -11.04% |
| Income Tax Expenses | 19.14% | -152.77% | -158.75% | 118.22% | 152.69% |
| Earnings from Continuing Operations | -1,773.92% | -1,852.77% | -1,455.24% | -3,735.95% | -109.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 143.13% | 100.00% | -291.86% | -302.63% |
| Net Income | -1,748.94% | -1,807.25% | -1,439.78% | -3,715.44% | -115.82% |
| EBIT | -637.89% | -567.60% | -186.47% | -4.37% | 52.12% |
| EBITDA | -415.39% | -382.46% | -112.50% | -15.96% | 1.98% |
| EPS Basic | -951.92% | -1,021.10% | -816.44% | -1,874.97% | -90.39% |
| Normalized Basic EPS | 21.52% | -208.51% | -30.55% | 48.66% | -52.04% |
| EPS Diluted | -951.92% | -1,021.10% | -816.44% | -1,874.97% | -90.39% |
| Normalized Diluted EPS | 21.52% | -208.51% | -30.55% | 48.66% | -52.04% |
| Average Basic Shares Outstanding | 101.45% | 69.80% | 22.58% | 5.83% | -8.83% |
| Average Diluted Shares Outstanding | 101.45% | 69.80% | 22.58% | 5.83% | -8.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |